About Rajasthan Antibiotics Ltd
Data last updated:
Rajasthan Antibiotics Ltd is a public limited company based in New Delhi, Delhi, India, a subsidiary of Manvin Health Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 March 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1986PLC023616. Its GSTIN is 07AAACR0925L2ZD (Delhi). The company holds 6 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹13.88 Cr and a paid-up capital of ₹9.57 Cr. It was formerly known as Cepham Medical Leasing Ltd. It is led by directors including Aashish Pruthii (Managing Director) and Rakesh Kumar Girdhar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 14 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M – 134 2nd Floor, Connaught Circus, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2025, the company reported a revenue of ₹383.3 Cr. For the same year it recorded a net profit of ₹23.52 Cr (net margin 6.1%) and EBITDA of ₹35.9 Cr (EBITDA margin 9.4%).
The company has about 314 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Rajasthan Antibiotics. As per MCA filings, the company has open charges of ₹117.84 Cr and satisfied charges of ₹729.68 Cr on record. Court records list 29 cases involving the company, including 15 filed by the company and 14 filed against it; 13 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rallife.com.
Company details
Contact details
Rajasthan Antibiotics Ltd's registered office is in New Delhi, Delhi. Its website is rallife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressM – 134 2nd Floor, Connaught Circus, New Delhi, Delhi, India – 110001
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of Rajasthan Antibiotics Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Rajasthan Antibiotics operates one associated brand: Rajasthan Antibiotics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces and exports sterile APIs like antibiotics and inhibitors worldwide. | rallife.com |
Business activity
The main business activity of Rajasthan Antibiotics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rajasthan Antibiotics Ltd, buy the company report.
Financials of Rajasthan Antibiotics Ltd
FY 2025 filings availableRajasthan Antibiotics Ltd reported revenue of ₹383.3 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹383.3 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35.9 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23.52 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.4% | ||||
| Net Profit Margin | 6.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rajasthan Antibiotics Ltd, buy the company report.
Board of directors of Rajasthan Antibiotics Ltd
Rajasthan Antibiotics has 6 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aashish Pruthii Also directs: Ral Nutralife Private Limited | Managing Director | 01 Jan 2007 | 19 Years 10 Months | Current |
| Bindu Acharya Also directs: Tarc Limited | Director | 03 Jan 2022 | 4 Years 9 Months | Current |
| Vijaysinh Vanvirsinh Chauhan Also directs: Bridgecare F and D Private Limited, Neo India Lifeline Private Limited, Curidox Pharmaceuticals Private Limited and 2 more | Director | 19 May 2022 | 4 Years 5 Months | Current |
| Arvind Kharabanda Also directs: Kharabanda A S & Associates LLP, HFCL Limited, HFCL Advance Systems Private Limited and 4 more | Director | 19 May 2022 | 4 Years 5 Months | Current |
| Rakesh Kumar Girdhar Also directs: Ral Nutralife Private Limited | Whole-Time Director | 01 Nov 2008 | 18 Years 0 Months | Current |
| Rajesh Kumar Jha | Director | 29 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Rajasthan Antibiotics Ltd is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hetero Biopharma Limited | ₹387.48 Cr (FY 2024) | 13.0% | Hyderabad, Telangana, India | |||
| Astec Lifesciences Limited | ₹386.93 Cr (FY 2025) | -17.0% | Mumbai, Maharashtra, India | |||
| Syschem (India) Limited | ₹386.27 Cr (FY 2025) | 65.0% | Haryana, India | |||
| Tatva Chintan Pharma Chem Limited | ₹385.03 Cr (FY 2025) | -4.0% | Ankleshwar, Gujarat, India | |||
| Zim Laboratories Limited. | ₹384.82 Cr (FY 2025) | 3.0% | Nagpur, Maharashtra, India | |||
| Rajasthan Antibiotics Ltdthis company | ₹383.3 Cr (FY 2025) | ₹23.52 Cr | 6.1% | 314 | New Delhi, Delhi, India | |
| Marc Laboratories Limited | ₹383.21 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Caplin Steriles Limited | ₹377.24 Cr (FY 2025) | 18.0% | Chennai, Tamil Nadu, India | |||
| NGL Fine-Chem Limited | ₹376.89 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| MSN Organics Private Limited | ₹376.38 Cr (FY 2024) | 75.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Rajasthan Antibiotics Ltd, buy the company report.
Auditor
Rajasthan Antibiotics Ltd is audited by T R Chadha & Co LLP for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T R Chadha & Co LLP | FY 2025 | 006711N/N500028 |
Shareholding
The shareholding of Rajasthan Antibiotics Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rajasthan Antibiotics Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Dec 2024 | 101020708 | Yes Bank Limited | ₹19.5 Cr | Open | |
| 02 Dec 2024 | 101051050 | Indian Bank | ₹7.5 Cr | Open | |
| 19 Mar 2024 | 100899398 | Indian Bank | ₹3.4 Cr | Open | |
| 19 Jan 2024 | 100892206 | Hdfc Bank Limited | ₹5.23 Lakh | Open | |
| 05 Jun 2023 | 100733042 | Indian Bank | ₹4 Cr | Open |
To see the full charge records of Rajasthan Antibiotics Ltd, buy the company report.
Total charge records: 51 View all charges
Legal cases
Rajasthan Antibiotics Ltd has 29 court cases on record: 15 filed by Rajasthan Antibiotics, 14 filed against it. 13 cases are pending and 16 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 21 | 7 | 10 |
| High courts | 8 | 7 | 3 |
Cases on record (5 of 29)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Silvassa, DNH at Silvasa | Civil suit | Filed against the company by M/S Ami Polymer Pvt. Ltd. | Pending |
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed by the company against Mac Chem Products India Pvt Ltd and 1 other | Pending |
| District court, New Delhi, Delhi | Revision petition | Filed by the company against Vexta Laboratories Pvt Ltd | Pending |
| District court, New Delhi, Delhi | Court case (Cr Cases) | Filed by the company against Vexta Laboratories P.Ltd | Pending |
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed by the company against Ang Lifesciences India Ltd | Disposed |
To see the full case history of Rajasthan Antibiotics Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Rajasthan Antibiotics Ltd has 9 MSME Form 1 returns on record between 2022 and 2023, listing 1,324 overdue payments to 44 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 44)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Aam Aan Kay Gases Private Limited | |||
| Continental Carriers Private Limited | |||
| Kumar Containers Private Limited | |||
| A.G. Gasochem Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Rajasthan Antibiotics Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Rajasthan Antibiotics has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Ral Nutralife Private Limited | U51909UP2019PTC122131 |
To see the full group structure of Rajasthan Antibiotics Ltd, buy the company report.
Employees & EPFO
Rajasthan Antibiotics Ltd has a workforce of 314 employees on its EPFO records as of Sep 23, 2025, across 1 active EPFO establishment.
GST
Rajasthan Antibiotics has 6 GST registrations: 2 active and 4 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACR0925L2ZD | Delhi | Active | 21 Sep 2017 |
| 08AAACR0925L1ZC | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rajasthan Antibiotics Ltd, buy the company report.
Recent activity
Rajasthan Antibiotics Ltd has 18 board changes on record since 2007: 6 appointments and 12 cessations. The latest: Mona Kaushik ceased to be Company Secretary on 10 Feb 2023.
110 earlier events are in the company report.
Frequently asked questions
Rajasthan Antibiotics is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 March 1986 (40+ years old) and is registered under CIN U24231DL1986PLC023616.
Rajasthan Antibiotics has 6 current directors:
- Aashish Pruthii - Managing Director
- Rakesh Kumar Girdhar - Whole-Time Director
- Bindu Acharya - Director
- Vijaysinh Vanvirsinh Chauhan - Director
- Arvind Kharabanda - Director
- Rajesh Kumar Jha - Director
The latest financial statements of Rajasthan Antibiotics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 14 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rajasthan Antibiotics is 07AAACR0925L2ZD, registered in Delhi. The company has 6 GST registrations in all, of which 2 are active and 4 are cancelled or inactive. Other active GSTINs include 08AAACR0925L1ZC (Rajasthan).
The CIN (Corporate Identification Number) of Rajasthan Antibiotics is U24231DL1986PLC023616. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rajasthan Antibiotics has 29 court cases on record: 15 filed by the company and 14 filed against it. 13 are pending. Most are in the district courts.
Rajasthan Antibiotics was incorporated on 17 March 1986, making it 40+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rajasthan Antibiotics by revenue are Hetero Biopharma Limited, Astec Lifesciences Limited, Syschem (India) Limited, Tatva Chintan Pharma Chem Limited, Zim Laboratories Limited. and 4 more, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mona Kaushik ceased to be Company Secretary on 10 Feb 2023. Arvind Kharabanda was appointed as Director on 19 May 2022. Vijaysinh Vanvirsinh Chauhan was appointed as Director on 19 May 2022. Rajasthan Antibiotics has 18 board changes on record in total.
Rajasthan Antibiotics has 9 MSME Form 1 returns on record between 2022 and 2023, listing 1,324 overdue payments to 44 micro and small suppliers. The latest return was filed on 27 Dec 2023.
Rajasthan Antibiotics can be reached through the website rallife.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Rajasthan Antibiotics is at M – 134 2nd Floor, Connaught Circus, New Delhi, Delhi, India – 110001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
